Author: Fiona Craig

Blackbird PLC (LSE:BIRD) has unveiled a new partnership between its cloud-based video editing platform, elevate.io, and Barclays Eagle Labs. Together, they will deliver workshops designed to equip entrepreneurs with essential video production skills. By using elevate.io’s accessible and collaborative editing tools, the program aims to help founders enhance their storytelling abilities, strengthen their brand presence, and ultimately support business growth.

Despite ongoing financial pressures linked to profitability and cash flow, Blackbird maintains a solid equity base and continues to advance strategic initiatives that could drive future expansion. While valuation concerns remain given its negative earnings, technical indicators point to relative stability, and recent corporate developments offer reasons for cautious optimism.

About Blackbird PLC

Operating within the SaaS, Media & Entertainment, and digital content creation sectors, Blackbird PLC delivers innovative cloud-native video solutions for broadcasters, rights holders, and media owners. Its flagship offering, elevate.io, is a collaborative, browser-based editing platform tailored for professional teams and the Creator Economy. By combining scalability with intuitive design, Blackbird seeks to capitalize on the rising demand for flexible, cloud-enabled content production tools.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cizzle Biotechnology Holdings PLC (LSE:CIZ) has reported major progress in its U.S. commercialization strategy. Its North American partner, Cizzle Bio Inc., has signed an agreement with a leading national clinical diagnostics group to introduce the CIZ1B biomarker test across the United States. The initiative is designed to strengthen Cizzle’s market footprint in North America and broaden access to early-stage lung cancer screening.

As part of the arrangement, Cizzle and Cizzle Bio have also agreed to a revised royalty payment structure. Under the new schedule, all outstanding advance royalties will be fully paid by the end of 2026—earlier than originally planned. The adjustment highlights both partners’ commitment to accelerating deployment of the test while improving Cizzle’s financial outlook through faster revenue recognition.

About Cizzle Biotechnology Holdings PLC

Based in the UK, Cizzle Biotechnology is dedicated to advancing diagnostics for early cancer detection. Its flagship product, the CIZ1B biomarker, has been developed into a cost-effective, non-invasive blood test aimed at detecting lung cancer at earlier, more treatable stages. The company operates under a licensing model that generates royalties from commercialization agreements and works alongside leading cancer research institutions. Cizzle was admitted to the London Stock Exchange in May 2021.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Defence Holdings PLC (LSE:ALRT) has strengthened its leadership team with the appointment of Andrew McCartney, former head of Microsoft Ventures UK, as its new Chief Technology Officer. Recognized as an innovator in artificial intelligence for national security applications, McCartney will oversee the development of the company’s AI-driven product portfolio. His expertise is expected to accelerate Defence Holdings’ shift toward software-first solutions, reinforcing its ambition to play a central role in the digital transformation of the global defence sector.

This appointment underscores the company’s strategic focus on building sovereign digital capabilities. By leveraging McCartney’s extensive background in deploying AI systems in complex operational environments, Defence Holdings aims to expand its influence and competitiveness within the defence technology landscape.

About Defence Holdings PLC

Headquartered in London, Defence Holdings PLC is a publicly listed company specializing in next-generation defence technologies. Its work spans AI-enabled analytics, autonomous platforms, secure communications, and mission-critical infrastructure across multiple domains, including land, sea, air, space, and cyber. With a strategy rooted in partnerships and capital markets expertise, Defence Holdings seeks to advance European defence capabilities and deliver cutting-edge solutions for modern security challenges.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Georgina Energy plc (LSE:GEX) has taken another step forward with its Hussar EP513 project in Western Australia by filing a revised Environmental Management Plan aimed at securing drilling approval. The company is actively engaging with regulators and indigenous groups to ensure all environmental and community standards are met. Although progress has been slowed by unforeseen factors such as adverse weather, management remains confident that approval will be granted in the near term, paving the way for site preparations and drilling activity.

While operational progress is being made, Georgina Energy continues to grapple with severe financial pressures. Losses, negative cash flow, and limited liquidity weigh heavily on the company’s performance outlook. Despite some neutral momentum in technical indicators and strategic moves that could support future growth, its fragile balance sheet makes the investment case high-risk, requiring caution from shareholders and prospective investors.

About Georgina Energy plc

Georgina Energy aims to establish itself as a key participant in the global energy transition, focusing on the supply of helium and hydrogen. Operations are conducted through its Australian subsidiary, Westmarket Oil & Gas Pty Ltd, which holds exploration interests in both the Hussar Prospect in Western Australia and the Mt Winter Prospect (EPA155) in the Northern Territory. With a strategy centered on meeting the rising demand for helium and hydrogen, Georgina Energy seeks to leverage its asset base and management expertise to build a competitive position in these emerging markets.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Ilika plc (LSE:IKA) has marked an important step forward in its collaboration with Cirtec Medical, successfully completing the manufacturing process qualification for its Stereax micro-batteries at Cirtec’s facility in the United States. With this milestone achieved, production is now moving into the phase of product testing and initial shipments to customers. The development strengthens opportunities for next-generation miniaturized power solutions, particularly for implantable medical technologies.

By merging Ilika’s innovation in solid-state battery design with Cirtec’s specialized manufacturing capabilities, the partnership is well positioned to address the rising demand for compact, high-performance batteries that support advanced medical implants.

Despite the technical progress, Ilika continues to face notable financial headwinds and valuation pressures. These challenges are partly balanced by encouraging corporate developments and ongoing advances in its technology pipeline. The company’s ability to secure funding and move its products closer to commercialization remains critical to its outlook.

About Ilika plc

Ilika is recognized internationally for its expertise in solid-state battery innovation across multiple industries, including electric mobility, medical devices, and consumer electronics. The company’s portfolio includes two core product families: Stereax micro-batteries, tailored for miniature implants and IoT applications, and Goliath large-format cells, developed for electric vehicles and cordless appliances. Operating primarily through a licensing model, Ilika provides its intellectual property to original equipment manufacturers and production partners to bring its technology to market.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Oil edged higher on Thursday as traders focused on the potential effects of a high-stakes meeting between U.S. and Russian leaders on global supply.

As of 08:45 ET (12:45 GMT), October Brent futures were up 0.5% at $65.94 per barrel, while West Texas Intermediate (WTI) gained 0.5% to $62.97 per barrel. Despite the intraday rise, both benchmarks remain on track to post weekly losses of roughly 1%.

Ceasefire Discussions in Alaska Take Center Stage

U.S. President Donald Trump and Russian President Vladimir Putin are scheduled to meet in Alaska on Friday to discuss terms for a potential ceasefire in Ukraine. On Wednesday, Trump warned of “severe consequences” if Putin failed to agree to peace, having previously threatened hefty tariffs on key buyers of Russian oil, including India and China.

Any implementation of these measures—or additional restrictions on Russia’s energy sector—could tighten global oil supplies and offer support to crude prices. Conversely, easing sanctions could put downward pressure on the market.

“Clearly, there’s upside risk for the market if little progress is made,” said ING analysts in a note. “This could have Trump extending secondary tariffs on other buyers of Russian energy. The expected oil surplus through the latter part of this year and 2026, combined with OPEC spare capacity, means that the market should be able to manage the impact of secondary tariffs on India. But things become more difficult if we see secondary tariffs on other key buyers of Russian crude oil, including China and Turkey.”

Supply Outlook and Rising Inventories Weigh on Oil

This week’s losses were driven by bearish signals from both the U.S. government and the International Energy Agency (IEA). The IEA said global oil supplies appear “bloated,” pointing to consistent production increases by OPEC+ throughout the year. The agency also forecast a looming supply glut in 2025 and 2026 and predicted a slowdown in demand in the near term, projecting a surplus of 3 million barrels per day in 2026.

Further pressure came from U.S. data showing a 3 million-barrel increase in crude inventories last week, far above expectations for a 0.9 million-barrel draw. Analysts noted this build reflects the winding down of the U.S. summer travel season, which typically drives three months of strong fuel demand before declining through autumn and winter.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

European equity markets climbed to their highest level in two weeks on Thursday as investors weighed a flood of corporate results alongside stronger-than-expected U.K. economic data.

Figures from the Office for National Statistics revealed that Britain’s economy expanded by 0.4% in June, recovering from a 0.1% dip in May and outpacing forecasts for 0.2% growth.

In index performance, London’s FTSE 100 gained 0.1%, while France’s CAC 40 and Germany’s DAX each advanced 0.6%.

Among individual movers, German meal-kit provider HelloFresh (BIT:1HFG) sank 16% after cutting its full-year forecast, citing weaker demand and the impact of a stronger euro.

Industrial group Thyssenkrupp (BIT:1TKA) dropped 6.4% following a downgrade to its investment and sales outlook. Power utility RWE (TG:RWE) slipped 3.5% after first-half core profit fell short of expectations.

Swedish video game publisher Embracer Group AB (TG:TH92) plunged 23% as its first-quarter operating profit missed market projections. In the U.K., Grosvenor casino owner Rank Group (LSE:RNK) slid 4.7% despite a sharp rise in annual profits to June 30, 2025.

On the upside, insurer Aviva (LSE:AV.) jumped nearly 5% after reporting a 22% increase in first-half operating profit, while Admiral Group (LSE:ADM) surged 6.4% on a 67% rise in half-year pretax earnings.

National Grid (LSE:NG.) gained 1.3% after agreeing to sell its Grain LNG business to a consortium including Centrica plc and Energy Capital Partners LLC. Swiss Re (TG:SR9) climbed 2.2% as the reinsurer reaffirmed its full-year guidance following solid second-quarter results.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

U.S. stock index futures edged lower Thursday morning, hinting at a pullback after two straight days of gains, as investors digested a hotter-than-expected wholesale inflation report.

The latest data from the Labor Department showed producer prices in July climbed sharply, with the Producer Price Index (PPI) for final demand rising 0.9% month-over-month, following a flat reading in June. Economists had anticipated a far smaller 0.2% increase.

On an annual basis, producer price growth accelerated to 3.3% from June’s upwardly revised 2.4%. Market forecasts were looking for a more modest uptick to 2.5% from the previously reported 2.3%.

The surprise jump in wholesale inflation tempered the optimism sparked earlier in the week by consumer price data that reinforced expectations of a September rate cut by the Federal Reserve. Even so, CME Group’s FedWatch tool still assigns a 94.6% probability that the central bank will trim rates by a quarter percentage point next month.

On Wednesday, equities initially extended Tuesday’s rally before paring gains. The Nasdaq added 31.24 points, or 0.1%, to 21,713.14, while the S&P 500 climbed 20.82 points, or 0.3%, to a fresh record close of 6,466.58. The Dow Jones Industrial Average outperformed with a 463.66-point jump, or 1.0%, to 44,922.27, boosted by strong moves in UnitedHealth (NYSE:UNH), Nike (NYSE:NKE), Sherwin-Williams (NYSE:SHW), and Merck (NYSE:MRK).

The week’s earlier gains were fueled by rate-cut hopes after consumer inflation numbers largely matched forecasts. Treasury Secretary Scott Bessent has urged the Fed to keep the option open for a bigger 50-basis-point reduction, pointing to recent softness in the labor market. President Donald Trump has also kept up public pressure on Fed Chair Jerome Powell, even threatening to let a “major lawsuit” tied to headquarters renovations proceed.

Sector-wise, housing stocks led the market Wednesday, with the Philadelphia Housing Sector Index up 3.7%, its best close in eight months. Biotech names also rallied, lifting the NYSE Arca Biotechnology Index 3% to a five-month high. Airline, pharmaceutical, and computer hardware stocks posted notable gains, while brokerage and software shares lagged.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

U.K. equities edged lower on Thursday despite data showing stronger-than-expected economic growth in June, alongside corporate updates from insurers Aviva and Admiral.

At 0902 GMT, the FTSE 100 inched up 0.05%, while the British pound ticked higher by 0.01% against the dollar, reaching 1.35. Across Europe, Germany’s DAX rose 0.2% and France’s CAC 40 gained 0.3%.

U.K. Economy Expands Faster than Expected in June

Following two months of contraction, the U.K. economy grew 0.3% in June, exceeding the 0.1% forecast, according to the Office for National Statistics. However, overall growth in Q2 slowed to 0.3% from 0.7% in the first quarter.

Aviva Shares Rise on Strong H1 Profit

Aviva (LSE:AV.) shares gained 2% at the open after the insurer reported first-half results that exceeded expectations. Operating profit for the six months ending June 30 climbed 22% to £1.07 billion ($1.45 billion), beating the £972 million consensus. Performance was driven by higher premiums and net inflows in its wealth division, with the company reaffirming its full-year guidance.

Admiral Posts Earnings Beat

Shares of Admiral Group (LSE:ADM) rose over 5% following a 69% surge in earnings, supported by a 56% increase in UK motor profits. Group pre-tax profit came in 2.6% above consensus, while the UK motor division surpassed forecasts by 5.9%. Household profit exceeded estimates by 32.6%, and travel and pet insurance losses were smaller than expected (£0.1 million vs. £1 million forecast).

PensionBee Gains on Asset Growth and UK Profitability

PensionBee Group plc (LSE:PBEE) shares rose 1.05% after reporting a 21% year-over-year increase in assets under administration to £6.3 billion, driven by net inflows of £423 million. Revenue grew 23% to £18.9 million, while the number of invested customers increased 14% to 286,000. The company also achieved profitability in its U.K. operations.

Antofagasta H1 Results Exceed Expectations

Antofagasta plc (LSE:ANTO) reported robust first-half 2025 financials, with EBITDA of $2.2 billion roughly in line with consensus but slightly above expectations due to lower operating costs. Underlying EPS reached $0.47, beating RBC forecasts by 24% and consensus by 6%. A first-half dividend of $0.17 per share was declared, 24% higher than RBC’s projection and 5% above consensus, consistent with the company’s 35% payout policy.

Centrica Stock Rises on LNG Terminal Deal

Centrica plc (LSE:CNA) shares climbed 1.5% after announcing the acquisition of the Isle of Grain liquefied natural gas terminal in partnership with Energy Capital Partners. The enterprise value of the deal is £1.5 billion, with Centrica taking a 50% stake and an equity investment of roughly £200 million, supported by approximately £1.1 billion in non-recourse project financing.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Antofagasta Plc (LSE:ANTO) reported stronger-than-anticipated first-half 2025 results on Thursday, though ongoing maintenance at its Los Pelambres mine is likely to push full-year copper production toward the lower end of guidance.

The London-listed miner posted group EBITDA of $2.2 billion for the six months ending June 30, roughly 2% above both company consensus and analyst projections. Earnings per share also outperformed expectations, coming in 8% higher than consensus, with RBC noting a 24% beat relative to its own forecast.

Analysts described the results variously as a “clean beat” (RBC), “decent” (Barclays), and a “mixed bag” (Morgan Stanley).

The company announced an interim dividend of 16.6 cents per share, consistent with its 35% payout policy. This distribution was 5% above consensus and 24% higher than RBC’s forecast, with Barclays and Morgan Stanley noting it exceeded their projections by 3% to 5%.

While guidance for full-year production and costs remains unchanged, Antofagasta said extra maintenance on the Los Pelambres tailings pipeline in July and August would reduce copper output by 5,000–10,000 metric tons. This adjustment places total 2025 production toward the bottom of the 660,000–700,000 metric ton range.

Barclays and Morgan Stanley cautioned that this maintenance could temper market reaction despite a solid first half. Morgan Stanley also highlighted that only 41% of Antofagasta’s $3.9 billion capital expenditure budget had been spent in H1, suggesting a significant ramp-up is needed in the second half to meet full-year targets.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.